H&S challenges in the Republic of Marshall Islands (RMI) & Solutions Read more about H&S challenges in the Republic of Marshall Islands (RMI) & Solutions
H&S challenges in Papua New Guinea (PNG) & Solutions Read more about H&S challenges in Papua New Guinea (PNG) & Solutions
H&S challenges in Kiribati (KIR) & Solutions Read more about H&S challenges in Kiribati (KIR) & Solutions
MODULE 7: Emergency Preparedness and Response Read more about MODULE 7: Emergency Preparedness and Response Participants able to: » Understand the best practices involved in emergency response situations » Outline the escalating Levels of Emergency » Explain the Incident Command System (ICS) » ICS Roles and Responsibilities
MODULE 6 – Incident Reporting and Investigation Read more about MODULE 6 – Incident Reporting and Investigation Participants able to: » Understand Roles and Responsibilities for Incident Management and Reporting » Describe incident investigation techniques including Root Cause Analysis » Discuss the importance of sharing Lessons Learned to prevent recurrence (Continuous Improvement)
MODULE 2 – H&S Risk Assessment Read more about MODULE 2 – H&S Risk Assessment » Explain the principles of Risk Assessment » Know the relationship between a Hazard and a Risk » Understand the principle of As Low As Reasonably Practicable » Use a Risk Matrix » Describe Hazard Groups and the Hazard Wheel » Provide an example of how a person could be harmed for each hazard group
Priscilla Rupali Keywords COVID-19 SARS ADB Clinical trial vaccine safety Health Read more about Priscilla Rupali Dr. Priscilla Rupali is Professor and head of Dept. of Infectious Diseases, Christian Medical College (CMC), Vellore, India. She was a Senior ID fellow in the Dept. of Adult Infectious Diseases, Auckland City Hospital and has a "Diploma in Tropical Medicine and Hygiene" from Universidad Cayetano Heredia, Lima. She runs an annual course in Clinical Tropical Medicine at CMC. Early 2000s, she joined in pioneering distance learning course educating people in HIV Medicine.
Post-Authorization Safety Monitoring Read more about Post-Authorization Safety Monitoring This presentation gives an overview of Dr. Salmon's presentation on why safety monitoring is important after vaccination. Dr. Salmon also shared insights on adverse events following immunization and limitations of clinical trials. He also presented several case findings following COVID-19 vaccines.
Daniel Salmon Keywords COVID-19 vaccine ADB John Hopkins SARS Clinical trial safety Health Read more about Daniel Salmon Dr. Salmon’s primary research and practice interest is optimizing the prevention of childhood infectious diseases through the use of vaccines. He is broadly trained in vaccinology, with an emphasis in epidemiology, behavioral epidemiology, and health policy. Dr.